United States

Showing 291-300 of 353 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Stromal Cell Targeted Tolerogenic mRNA Therapy for T1D	Endotope Biosciences	Raymond Liang	Cures	15-December-2025 to 14-December-2027	$550,417.82
ENCRT-hPI (Immune-Protected ENCRT Extension Study), Evaluation of an immune-protected ENCRT-101 loaded with primary human islets in adults with Type 1 Diabetes, with and without standard-of-care portal vein islet infusion.	Encellin	Crystal Nyitray	Cures	25-June-2026 to 24-June-2028	$2,500,000.00
Evaluating the Effectiveness and Safety of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 1 Diabetes	Emory University	Piaopiao Li	Improving Lives	01-July-2025 to 30-June-2027	$599,998.91
Impact of Inflammatory Cytokines on ER-Mitochondria Crosstalk and Proinsulin Folding in Beta Cells	East Tennessee State University	Anoop Arunagiri	Cures	01-August-2025 to 31-July-2027	$241,431.00
ACTin1 for DD: Developing and Testing a Digital Single Session Acceptance and Commitment Therapy Intervention for Type 1 Diabetes Distress	Duke University	Max Roberts	Improving Lives	01-April-2026 to 31-March-2029	$241,710.00
Pilot Testing a Digital Single Session Intervention for Diabetes Distress	Duke University	Max Roberts	Improving Lives	01-October-2026 to 30-September-2027	$110,000.00
Changing the T1DE: A randomized controlled trial comparing ACT to supportive diabetes counseling	Duke University	Rhonda Merwin	Improving Lives	01-July-2022 to 30-June-2027	$2,758,224.22
Development of a tolerogenic hydrogel depot for islet cell protection	Drexel University	Christopher Rodell	Cures	01-November-2026 to 31-October-2029	$614,379.18
IND Readiness Gap Analysis and Risk Assessment	Dark Horse Consulting	Amanda Mack	Cures	15-June-2026 to 30-November-2026	$80,325.05
Broad Scope CMC, Non-Clinical, and Regulatory Support	Dark Horse Consulting	Nathan Manley	Cures	01-September-2025 to 31-December-2026	$85,000.00